INSTRUCTIONS FOR AUTHORS
The journal DiePharmazie
publishs reviews, experimental studies, letters to the editor, as
well as book reviews.
The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry,
pharmaceutical analysis and drug control, pharmaceutical technolgy, biopharmacy
(biopharmaceutics, pharmacokinetics, biotransformation), experimental and clinical
pharmacology, pharmaceutical biology (pharmacognosy), clinical pharmacy, history of pharmacy.
Articles are published in English and are classified as
Letters to the Editor
1. For submitted
manuscripts, it is the responsibility of the author(s) to demonstrate novelty or a new
approach taken in his research. The references should reflect the most recent relevant
articles, and the discussion should compare the authors findings with the results of
former investigations. For an experimental work, the data have to be determined and
classified in a suitable way, problems must be formulated in view of the data, hypotheses
should be suggested an/or the author should give possible explanations for any
A summarizing presentation encompassing the current state of our
knowledge and providing comprehensive interpretation with
citation of the literature.
Publications from all fields mentioned above.
Brief publications about the fields mentioned above (see Preparation
Letters to the editor
If possible, the author(s) should perform mathematical or
statistical calculations, fit the curves appropriate, and carry out the experiments under
controlled conditions. Studies involving animals or human volunteers must include details
of ethical approval.
2. Authors are requested to submit all
manuscripts online .
Paper copy submissions are no longer
Articles are considered for publication depending on their value and pharmaceutical
relevance and with the understanding that they have not been published previously and are
submitted exclusively to the journal Die Pharmazie.
manuscripts are subject to experts review. Additional corrections may be done by the
4. A PDF-file of the article is delivered free of charge after the paper has
been published in the journal. Please note that, by copyright reasons, this is for personal
use of the authors only and must not be made available, e.g. by posting on a
freely accessible website.
5. Processing charges:
Publication fees for publication in DiePharmazie
are 250 per manuscript (+ 19%VAT), regardless of type and lenght. Authors will
receive an invoice right after acceptance. Papers will neither be
copy-edited nor typesetted
before the fee has been paid.
6. Delivery of a
PDF-file of the article is included in the publication fee. Please note that, by copyright
reasons, this is for personal use of the authors only and must not be made available, e.g.
by posting on a freely accessible website.
7. The quotation of registered names, trade names, trademarks, etc.
in this journal does not imply, even in the absence of a specific statement, that such
names are exempt from the relevant laws and regulations and therefore free for general
As the journal is publishing exclusively original research, significant
changes in authorship after submission will lead to manuscript rejection.
Processing charges will not be refunded in these cases.
Editors of PHARMAZIE fully support internationally accepted high ethical
standards in publication, as particularly outlined by the Committee on
Publication Ethics (COPE; publicationethics.org), the International
Committee of Medical Journal Editors (ICMJE;
the Council of Scientific Editors (CSE;
and the European Association of Science Editors (http://www.ease.org.uk/wp-content/uploads/ease_toolkit_seven_sins.pdf).
Authors are requested to inform themselves from these publications.
important aspects are presented here in brief:
All authors must disclose
any financial and personal relationships with other people or organizations
that could inappropriately influence (bias) their work. Examples of
potential conflicts of interest include employment, consultancies, stock
ownership, honoraria, paid expert testimony, patent
applications/registrations, and grants or other funding. If there are no
conflicts of interest then please state this: 'Conflicts of interest: none
declared'. Submission of manuscripts is not possible without a conflict of
Patients have a right to privacy that should not be violated without
informed consent. Identifying information, including names, initials, or
hospital numbers, should not be published in written descriptions,
photographs, or pedigrees unless the information is essential for scientific
purposes and the patient (or parent or guardian) gives written informed
consent for publication. Informed consent for this purpose requires that an
identifiable patient be shown the manuscript to be published. Authors should
disclose to these patients whether any potential identifiable material might
be available via the Internet as well as in print after publication. Authors
need to provide the journal with a written statement that attests that they
have received and archived written patient consent.
the work involves the use of human subjects, the author should ensure that
the work described has been carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Helsinki) for
experiments involving humans. This has to be stated in the manuscript.
Authors should also include a statement in the manuscript that informed
consent was obtained for experimentation with human subjects. The privacy
rights of human subjects must always be observed. All animal experiments
should comply with the ARRIVE guidelines
(http://www.nc3rs.org.uk/arrive-guidelines), the EU Directive 2010/63/EU for
or similar regulations. The authors should clearly indicate in the
manuscript that such guidelines have been followed.
Preparation of manuscripts
In order to achieve uniform presentation and to avoid unnecessary delays because of
further inquries, all authors are requested to observe the following guidelines:
1. Below the title, the surname(s) of the
author(s) with initials should be given without academic and professional degrees. The
full address of the author for correspondence should appear below author names. Details on
the institution where the work was done are requested and should be given above the title.
2. Each manuscript should
start with an abstract, containing the most essential results of the study.
Papers should be subdivided into chapters and subchapters according to the decimal system
3. To achieve clarity and brevity of the
presentation, original contribuitons should be subdivided after the abstract (see 2.) as
1. Introduction: This should
indicate the question under investigation which is generally based on a brief
interpretation of the literature considering the current state of knowledge in the
subfield and explaining the necessary theoretical foundations.
2. Investigations and results: Methods should only be described generally (see
"Experimental"), referring to previous or analogous studies. The presentation of
results should be precise, with necessary formulas (numbered in sequence with Arabic
numerals), diagrams, tables and figures added separately (together with the legend) to the
manuscripts. Numerical values of results should generally be presented either in tables or
curves (please mark statistical limits).
3. Discussion (unless covered by 2. as Investigations, results and discussion): It should not repeat
results already given, but should state the conclusions drawn from the results or provide
a theoretical debate and comparison with literature citations.
4. Experimental: This part
describes briefly the detailed experimental conditions. Unless directions taken from
literature have been modified, it suffices to refer to the original source. In the case of
well known inorganic or organic compounds chemical formulae or common abbrevations may be
used (e.g. NaCI, H2SO4, CH3OH, C6H6: Ac, Eth, Me, Phe, DMSO) under
"Experimental". In other parts of the paper this is not desirable.
Results of elemental analyses can be omitted if it is stated that all the results were in
an acceptable error range.
4. Short communications are
limited to 100 lines
(including short summary; subdivisions are not required; the "Experimental" - if
there is one - should be marked), up to 15 citations of literature and a maximum of 2
supplementary materials (schemes, figures, tables) are allowed.
5. Only the surnames of authors are given in
the text. When there are more than two authors, only the name of the first one is used,
followed by et al.
in the text have to be cited by author and year, if there are three or more authors, use
et al. (Miller 1997; Miller and Smith 2000; Miller et al. 2001). If the year is the same
for several references identify these with a, b, c etc (Smith 1998a; Smith 1998b etc.)
both in the text and in the reference list. At the end of the paper, references are listed
in alphabetical order under the first authors surname. All authors should be
given here. If there are several references to
items with the same first author, arrange these chronologically regardless the
alphabetical order of the co-authors ("alphabetic-chronological" order).
Journal names should be abbreviated according to
"Index Medicus" (Medline) or "Chemical Abstracts Service Source
Quotations have to follow the following style:
Lee J (2002) Formulation development of epidermal growth
factor. Pharmazie 57: 787 - 790.
Lee EB, Shin KH, Woo WS (1984) Pharmacological study on
piperine. Arch Pharm Res 7: 127 - 132.
Krishan K, Andersen ME (1994) Physiologically based
pharmacokinetic modeling in toxicology. In: Hayes W (ed.) Principles and methods of
toxicology, 3rd ed., New York, p. 149 187
7. For the identification of pharmaceutical
substances, the International Nonproprietary Names (INN) proposed or recommended
by the WHO should be used. Registered Trade Marks (usually indicated with R; in an article
this sign should only be used when it
is first mentioned or used in the summary), trivial names and chemical nomenclature can be
9. Nomenclature and spelling should conform
to the directions given by IUPAC and IUB.
9. Units of measurement are determined by
the directions of the International Units System SI as symbols; M instead of mol/l or
mol * l-1 is allowed
10. Botanical names (species, genus) should
be marked in italics.
11. The following abbreviations should be
used consequently (except in the title and all subtitles). All other abbreviations have to
be explained in the manuscript at first usage, if aforementioned directions are not
applicable. Abs. = absolute: anh. = anhydrous;
b.p.; b.r. = boiling point, -range; calcd. = calculated; CC = column chromatography; conc.
= concentrated; dec. = decomposition ,
eq. = equation; Fig. = figure; GC = gas chromatography, - chromatogram, HPLC = high
performance liquid chromatography, -
chromatogram; i.m. = intramuscular; i.p. = intraperitoneal; IR = infrared; i.v. =
intravenous; m.p.; m.r. = melting point, -range; MS
= mass spectometry, mass spectrum; NMR = nuclear magnetic resonance spectrum; PC = paper
chromatogram, % = per cent, percentage, p.o. = peroral; s.c. = subcutaneous; TLC = thin
layer chromatography, - chromatogram;
UV = ultraviolet.
12. Footnotes must be numbered consecutively
and are to be added separately to the manuscript. They are printed following the
13. Dedications (e.g., on the occasion of
the 60th or higher birthday) should be inserted between author(s) and summary.
14. Additions to legends of table should be
marked by *,**,*** or a, b, c, d etc.
15. Figures have to be of sufficient quality
for reproduction process. Even after size reduction the figures' key has to be easy to
read. Manuscripts containing figures of insufficient quality cannot be accepted.